Medifast Inc
MED- Exchange
- NYSE
- Industry
- Miscellaneous Food Preparations & Kindred Products
- SEC CIK
- 0000910329
In the last 90 days, Medifast Inc insiders filed 3 open-market purchases and 0 sales; 112 institutions reported holding it in 13F filings for Q2 2026, worth $87.7M in total; no superinvestor holds it.
Key figures
- Insider buysLast 90 days, $1.42M in total
- 3
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +1 vs. previous quarter
- 112
- 13F valueReported value at the end of Q2 2026
- $87.7M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding MED, Q2 2026
No superinvestor reported holding MED at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Medifast Inc insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 28, 2026 (view filing)12:47 PM ET | Aug 26 | 2 days | Kiai ParsaDirector | PPurchase | +43.1K | $12.26 | +$529.2K | New position20.3K after | 2 lots |
| Aug 26, 2026 (view filing)11:47 AM ET | Aug 24 | 2 days | Kiai ParsaDirector | PPurchase | +4.33K | $12.00 | +$51.9K | +29.3%19.1K after | 2 lots |
| Aug 21, 2026 (view filing)12:35 PM ET | Aug 19-20 | 2 days | Kiai ParsaDirector | PPurchase | +72.5K | $11.63 | +$842.7K | New position19.0K after | 4 lots |
| May 12, 2026 (view filing) | May 8-11 | 4 days | Schlackman ScottDirector | PPurchase | +5.00K | $12.59 | +$63.0K | +19.6%30.5K after | 2 lots |
| Mar 27, 2026 (view filing) | Mar 20 | 7 daysLate | Chard Daniel RChairman & CEO | PPurchase | +17.7K | $10.11 | +$178.7K | New position17.7K after | |
| Jun 17, 2025 (view filing) | Jun 13 | 4 days | Chard Daniel RChairman & CEO | PPurchase | +381 | $13.13 | +$5.00K | +0.3%149.7K after | |
| Mar 12, 2024 (view filing) | Mar 8 | 4 days | Schlackman ScottDirector | SSale | −4.05K | $39.44 | −$159.9K | −34.2%7.78K after | 2 lots |
| Nov 9, 2023 (view filing) | Nov 7 | 2 days | Thomas Andrea BDirector | PPurchase | +50.39 | $68.89 | +$3.47K | +0.8%6.25K after | |
| Nov 9, 2023 (view filing) | Nov 7 | 2 days | Hoer Michael A.Director | PPurchase | +49.76 | $68.89 | +$3.43K | +0.6%8.38K after | |
| Nov 9, 2023 (view filing) | Nov 7 | 2 days | Schlackman ScottDirector | PPurchase | +52.65 | $68.89 | +$3.63K | +0.5%10.5K after |
Top 10 13F holders, Q2 2026
The largest institutional positions in Medifast Inc at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 778,610 | $8.26M | 0.01% | +4,900+0.6% | Added |
| Steamboat Capital Partners, LLC | 706,699 | $7.50M | 1.60% | −891−0.1% | Reduced |
| Two Sigma Investments, LP | 481,381 | $5.11M | 0.00% | +143,223+42.4% | Added |
| Vanguard Capital Management LLC | 446,614 | $4.74M | 0.00% | +2,147+0.5% | Added |
| Charles Schwab Investment Management Inc | 396,996 | $4.21M | 0.00% | −234,543−37.1% | Reduced |
| BlackRock, Inc. | 369,503 | $3.92M | 0.00% | −574,950−60.9% | Reduced |
| Dimensional Fund Advisors LP | 363,394 | $3.86M | 0.00% | +1,632+0.5% | Added |
| American Century Companies Inc | 318,911 | $3.38M | 0.00% | +94,631+42.2% | Added |
| Morgan Stanley | 292,508 | $3.10M | 0.00% | −32,804−10.1% | Reduced |
| Goldman Sachs Group Inc | 243,085 | $2.58M | 0.00% | +89,914+58.7% | Added |